Latest Close
$11.09
News
SGMT
Sagimet Biosciences Inc. - Seri News
This news view pulls recent coverage and headlines tied to SGMT.
1y Change
$4.57 (+70.09%)
Market Cap
$689,339,456.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Cantor Fitzgerald Initiates Coverage on Sagimet Biosciences With Overweight Rating
MT Newswires • Sep 9, 2026
Read articleBarclays Upgrades Sagimet Biosciences to Overweight From Equalweight, Adjusts Price Target to $18 From $8
MT Newswires • Sep 9, 2026
Read articleSagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
GlobeNewswire • Sep 2, 2026
Read articleSagimet Biosciences Says US Late-Stage Trial of Denifanstat to Treat Acne on Track for Q4 Enrollment
MT Newswires • Aug 25, 2026
Read articleSagimet Biosciences Advances AURORA U.S. Phase 3 Trial of Denifanstat in Acne Toward Patient Enrollment in Q4 2026
GlobeNewswire • Aug 25, 2026
Read articleSagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire • Aug 17, 2026
Read article